Magrolimab (anti-CD47)

Catalog No.A2036 Synonyms: 5F9, GS-4721,Hu5F9 G4,ONO 7913

For research use only.
Not for use in humans.

Magrolimab (anti-CD47) (5F9, GS-4721,Hu5F9 G4,ONO 7913) is a first-in-class macrophage immune checkpoint inhibitor that mainly binds to N-terminal pyroglutamate of CD47.

Magrolimab (anti-CD47)

Purity & Quality Control

Choose Selective Immunology & Inflammation related Inhibitors

Biological Activity

Description

Magrolimab (anti-CD47) (5F9, GS-4721,Hu5F9 G4,ONO 7913) is a first-in-class macrophage immune checkpoint inhibitor that mainly binds to N-terminal pyroglutamate of CD47.

Protocol (from reference)

Product Details

CAS No. 2169232-81-7
Molecular Weight 146 KD
Formulation PBS Buffer, PH 7.4
Isotype Human IgG4
Application Magrolimab (anti-CD47)
Source CHO cells
Storage Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles.
Sterility 0.2 μM filtered

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Magrolimab (anti-CD47) | Magrolimab (anti-CD47) supplier | purchase Magrolimab (anti-CD47) | Magrolimab (anti-CD47) cost | Magrolimab (anti-CD47) manufacturer | order Magrolimab (anti-CD47) | Magrolimab (anti-CD47) distributor